Skip to main content
. 2021 Sep 6;2021(9):CD011556. doi: 10.1002/14651858.CD011556.pub2

Gilbert 2017.

Study characteristics
Methods Design: Randomized controlled trial
Setting: General practices in England, UK
Recruitment: People who were currently smoking were identified from medical records in participating practices and sent an invitation letter
Participants 4384 adults who smoked, 50% M, av. age 49, av. cpd 16
99 general practices in 18 Stop Smoking Service areas
Interventions Intervention: participants received a brief personalized and tailored letter sent from the GP that included information specific to the participant and a personal invitation to attend a “come and try it” taster session for cessation services
Control: participants received a standard generic letter from the GP practice, which advertised the local SSS and asked the participant to contact the service to make an appointment to see an adviser
Outcomes 3m prolonged abstinence at 6m
Validation: Salivary cotinine level < 12 ng/mL
Quit attempts
Funding Source This study was funded by the National Institute for Health Research Health Technology Assessment Programme (project number 08/58/02).
Author's declarations of interest QUOTE: "Irwin Nazareth is a member of the National Institute for Health Research Health Technology Assessment Funding Commissioning Panel.
Notes Strategy: Tailored materials
Level: Patients
Comparison type: Single component vs. standard care
Risk of bias
Bias Authors' judgement Support for judgement
Sequence Generation Low risk Computer‐generated permutated block randomization
Allocation concealment Low risk Allocated by computer after participant consented
Blinding of outcome assessors
All outcomes Low risk Abstinence was biochemically validated. Participant contact was minimal in both groups.
Incomplete outcome data
All outcomes Low risk The overall loss to follow‐up was 23.1% (n = 1012/4384); 23.4% (n = 616/2636) in the intervention group and 22.7% (n = 396/1748) in the control group were lost to follow‐up at 6 months